Recent scientific evidence indicates that gut microbiota influence estradiol metabolism and are associated with the development of depression in nonpremenopausal women. Integrating existing studies on ...

Third-generation oral contraceptives (OCs) contain potent testosterone-derived progestagens and low doses of ethinyl estradiol. They are highly efficient and well tolerated, since the absolute ...

Mumbai: Glenmark Life Sciences, a developer and manufacturer of non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas, has announced its change of identity to Alivus ...

Glenmark Pharmaceuticals on Tuesday, January 21, said its US arm has launched Phytonadione Injectable Emulsion USP, 10mg/ml single dose ampules. It is bioequivalent and therapeutically equivalent to ...

Glenmark Pharmaceuticals share price: Pharmaceutical major Glenmark Pharmaceuticals shares rose up to 2.23 per cent to hit an intraday high of Rs 1,537.90 per share on Tuesday, January 21, 2025. The ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules. Glenmark's Phytonadione Injectable Emulsion USP, 10 mg/mL ...

The drug has given promising results for the treatment of multiple myeloma, a rare form of blood cancer. The market for such drugs is expected to touch USD30 billion by the end of the decade. Although ...

At a meeting organised in Hyderabad by the consumer care division of Glenmark, a leading Indian pharmaceutical company, over 100 roles from across India were made redundant in this division of the ...

Glenmark Life Sciences, a leading developer and manufacturer of select, high-value, non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas, announces its change of ...

Over 100 personnel with Glenmark Pharmaceuticals’ consumer care division have been retrenched, according to an industry source. The sales personnel were from across the country, and according to ...

BMC Clin Pharmacol. 2011;11(23):1-6. For the hyperkalemia analysis, in order to include only new users, patients were excluded if they did not have at least 180 days of enrollment history prior to ...